KYMR vs NFLX · rev $99.4M vs P/E 25, rev $12.56B
Kymera Therapeutics Inc (KYMR) versus Netflix Inc (NFLX) — a side-by-side from cached financials, not a winner call.
Kymera Therapeutics Inc (KYMR) is a biotechnology company listed on NASDAQ.
Netflix Inc (NFLX) is a entertainment company listed on NASDAQ.
Latest reported KYMR revenue for 2026-06-30 was $99.4M. Net income was -$130.4M. KYMR currently screens at market cap $7.39B.
Latest reported NFLX revenue for 2026-06-30 was $12.56B. Net income was $3.40B. Revenue was up 2.5% from 2026-03-31 to 2026-06-30. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
KYMR currently screens at market cap $7.39B. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
Not investment advice. Open the KYMR and NFLX stock pages for the full models.
Not investment advice.